Company intelligence / Profile preview

Anaphylaxis UK

Frimley, Surrey, United Kingdom

Ownership: Private
Development stage: Other

Overview

Anaphylaxis UK is a UK-based charity focused on supporting individuals at risk of severe allergic reactions (anaphylaxis), primarily through education, awareness, advocacy, and training. While deeply involved in healthcare and life science sectors, it does not directly develop or commercialize drugs, biologics, or devices.

Therapeutic areas: Immunology
Industry: Non-Academic Healthcare

Partnerships

Allergy UKBritish Society for Allergy & Clinical ImmunologyBritish Paediatric Allergy Immunity and Infection GroupRoyal College of Paediatrics and Child HealthFood Standards AgencyNational Allergy Strategy Group

Beyond the preview

Go deeper on Anaphylaxis UK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaphylaxis UK.

Explore the full profile